U.S., Jan. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07319442) titled 'CEDUR - German IBD Registry' on Dec. 07, 2025.
Brief Summary: The CEDUR registry systematically collects real-world data on inflammatory bowel disease (IBD) patients in Germany. The registry aims to assess quality of care, disease activity, treatment effectiveness, safety, and pharmacoeconomic aspects under routine clinical conditions.
Study Start Date: May 03, 2018
Study Type: OBSERVATIONAL
Condition:
Ulcerative Colitis (UC)
Indeterminate Colitis
Crohn Disease (CD)
Recruitment Status: RECRUITING
Sponsor: ImmunoRegister gUG
Disclaimer: Curated by HT Syndication....